Active — Not RecruitingNot Applicable

Breathwork-assisted Treatment for Cannabis Use Disorder

United States10 participantsStarted 2022-02-06

Plain-language summary

The purpose of this proof-of-concept study is to evaluate the safety, feasibility and acceptability of a breathwork workshop intervention in individuals with cannabis use disorder.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18-70 years of age * Meets Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) criteria for active cannabis use disorder. * Seeking treatment for their cannabis use Exclusion Criteria: * Meets DSM-V criteria for schizophrenia or any psychotic illness or any dissociative disorder (Dissociative identity disorder, Dissociative amnesia, Depersonalization/derealization disorder). * Active substance use disorder except for cannabis, nicotine, and caffeine. * History of severe withdrawal symptoms (i.e withdrawal seizures). * History of dementia, epilepsy or seizures, cardiac arrhythmia, pacemaker/defibrillator, heart failure, asthma, panic disorder and other respiratory illnesses (ie: COPD).

What they're measuring

Acceptability of the breathwork session

Timeframe: One week after the breathing session.

Safety of the breathing session

Timeframe: 24 hours after the breathing session.

Trial details

NCT IDNCT05219825

SponsorElias Dakwar

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-06-30

View on ClinicalTrials.gov More Addiction trials